Meet the Team Behind This Evidence Review

Device and indication assessment · skin-type risk and pigment change · reading a device claim

Dr. Ke He is Deputy Director of the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital and head of its skin and laser aesthetic service — and she is the lead physician of this site. A core specialist formerly at the Plastic and Aesthetic Surgery Department of Xinqiao Hospital, affiliated with Army Medical University, she has worked on the clinical front line in skin laser and injectable aesthetics for more than 20 years, serving over ten thousand patients.

On this review her part is the separation of what was measured from what was claimed. She works from the indication and the endpoint rather than from a device preference, describes tightening as the limited, variable change it is, and says plainly that no energy device is approved to lift tissue that has descended. She treats skin type and pigment history as the variables that decide the risk, which is why her assessment of a device plan starts with the person and not with the settings, and why she will describe a topical plan and sun protection as the better answer when the finding is a surface one that they can address.

Clinical focus

• Assessment of a specific finding: pigment, vessels, texture or laxity
• Skin-type and pigment-risk assessment before any device plan is discussed
• Reading a device claim against its indication and its approval
• Honest limits: what tightening can and cannot change about descent
• When topical treatment or doing nothing is the better-supported answer

Academic roles & achievements

• Member, Laser Medicine Group, Chinese Medical Association Plastic Surgery Branch
• Member, Facial Rejuvenation Group, Chinese Medical Association Plastic Surgery Branch
• Member, Chongqing Plastic Surgery Quality Control Center
• Published 5 papers, holds 5 national patents, and introduced 2 new clinical techniques

Center leadership and multidisciplinary case review

Dr. Shaoliang Wang is Director of the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team he provides the surgical perspective and the tertiary-hospital backstop — the assessment when an operation is the honest answer, and the hospital-level care for the rare complication that needs it.

Within the team, Shaoliang Wang contributes to the shared assessment of cases on this site.

Clinical focus

• Center leadership and multidisciplinary case review
• Surgical assessment when an operation is the honest answer to descent or excess skin
• Hospital-based care for the rare complication that needs theatre-level management

Aesthetic surgical assessment and refinement of contour and asymmetry

Dr. Tongchun Mao is an aesthetic surgeon within the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team his role is refinement and honest referral: he is the person who says so when an operation will do better than an injectable or a device.

Within the team, Tongchun Mao contributes to the shared assessment of cases on this site.

Clinical focus

• Aesthetic surgical assessment and refinement of contour and asymmetry
• Honest referral when surgery outperforms a course of injections
• Shared case planning within the four-physician team

Medical skin assessment behind injectable treatment plans

Dr. Yongbo Jia is a dermatologist within the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team his role is medical skin assessment — diagnosing and managing pigment and barrier conditions, and treating skin that a device or an injection has irritated.

Within the team, Yongbo Jia contributes to the shared assessment of cases on this site.

Clinical focus

• Medical skin assessment behind injectable treatment plans
• Diagnosis and management of pigment and barrier conditions
• Dermatologic care of skin after irritation or a delayed reaction